ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000

By: 3BL Media

SOURCE: Illumina

DESCRIPTION:

Illumina's NextSeq 1000/2000 sequencing systems are based on a technology that leverages light to decipher the genome. The instruments are used, among other things, to determine the genetic profile of the SARS-CoV-2 virus and its variants. The housing is made of high-grade aluminium and reflects the technological quality and precision of the instruments. The most striking design feature is the circumferential light bar that uses colour changes to make the working status clearly visible from all directions. The digital interface takes up the product aesthetics and creates a seamless user experience.

Statement by the Jury

The high design quality of the NextSeq 1000/2000 sequencing system manifests in elegant contours and the exciting use of light.

Tweet me: The NextSeq 1000/2000 System has been recognized as one of @Reddot’s 2021 Design Award winners. The high design quality of @Illumina’s NextSeq 1000/2000 sequencing system manifests in elegant contours and the exciting use of light. https://bit.ly/3B3aLZ0

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.94
+2.12 (0.98%)
AAPL  260.29
-2.23 (-0.85%)
AMD  199.45
-2.62 (-1.30%)
BAC  49.81
-0.49 (-0.97%)
GOOG  300.91
-2.54 (-0.84%)
META  660.57
-7.16 (-1.07%)
MSFT  410.68
+5.48 (1.35%)
NVDA  183.34
+0.30 (0.16%)
ORCL  154.79
+2.42 (1.59%)
TSLA  405.55
-0.39 (-0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.